The evolution of alternative splicing exons in vascular endothelial growth factor A

Gene

Volumn 487, Issue 2, 2011, Pages 143-150

  Xu, Jiaxi ^a   Dou, Tonghai ^a   Liu, Cong ^a   Fu, Maobin ^a   Huang, Yan ^a   Gu, Shaohua ^a   Zhou, Yan ^a,b   Xie, Yi ^a  

^a FUDAN UNIVERSITY   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Alternative splicing; Comparative genomics; ESE; VEGF

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN A 165B; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CAT; EXON; GAIN OF FUNCTION MUTATION; GENE CONTROL; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RABBIT; RAT;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CATS; EVOLUTION, MOLECULAR; EXONS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PAN TROGLODYTES; PHYLOGENY; PROTEIN ISOFORMS; RABBITS; RATS; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 80052899736     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.06.024     Document Type: Article

References (27)

1. Alexander V.A., Namshin K., Christopher J.L. Global analysis of exon creation versus loss and the role of alternative splicing in 17 vertebrate genomes. RNA 2007, 13:661-670.
2. Artac R.A., McFee R.M., Smith R.A., Baltes-Breitwisch M.M., Clopton D.T., Cupp A.S. Neutralization of vascular endothelial growth factor antiangiogenic isoforms is more effective than treatment with proangiogenic isoforms in stimulating vascular development and follicle progression in the perinatal rat ovary. Biol. Reprod. 2009, 81(5):978-988. Nov.
3. Cartegni L., Wang J., Zhu Z., Zhang M.Q., Krainer A.R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acid Res. 2003, 31(13):3568-3571.
4. Cui Tai-Gen, Foster Rebecca R., Saleem Moin, Mathieson Peter W., Gillatt David O., Bates David A., Bates Steven J., Harper Steven J. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. Am. J. Physiol. Renal Physiol. 2004, 286:767-773.
5. Dai J., Rabie A.B.M. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J. Dent. Res. 2007, 86:937.
6. David I.R., Holmes Ian Zachary The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005, 6(2):209.
7. Harper S.J., Bates D.O. VEGF-A splicing: the key to anti-angiogenic therapeutics. Nat. Rev. Cancer 2008, 8(11):880-887. Nov.
8. Hertel K.J., Lynch K.W., Maniatis T. Common themes in the function of transcription and splicing enhancers. Curr. Opin. Cell Biol. 1997, 9:350-357.
9. Irimia M., Rukov J.L., Roy S.W., Vinther J., Garcia-Fernandez J. Quantitative regulation of alternative splicing in evolution and development. Bioessays 2009, 31(1):40-50. Jan.
10. Jurica M.S., Moore M.J. Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell 2003, 12(1):5-14.
11. Lareau L.F., Brooks A.N., Soergel D.A.W., Meng Q., Brenner S.E. The coupling of alternative splicing and nonsense mediated mRNA decay. Alternative splicing in the postgenomic era 2007, 191-212. Landes Biosciences, Austin, TX. B.J. Blencowe (Ed.).
12. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
13. Merdzhanova G., Gout S., Keramidas M., Edmond V., Coll J.L., Brambilla C., Brambilla E., Gazzeri S., Eymin B. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo. Oncogene 2010, 29(39):5392-5403. Sep 30.
14. Nilsen T.W., Graveley B.R. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010, 463(7280):457-463. Jan 28.
15. Nowak D.G., Woolard J., Amin E.M., Konopatskaya O., Saleem M.A., Churchill A.J., Ladomery M.R., Harper S.J., Bates D.O. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J. Cell Sci. 2008, 121(Pt 20):3487-3495. Oct 15.
16. Otrock Z.K., Makarem J.A., Shamseddine A.I. Vascular endothelial growth factor family of ligands and receptors. Review Blood Cells Mol. Dis. 2007, 38(3):258-268. May-Jun.
17. Piekielko-Witkowska A., Wiszomirska H., Wojcicka A., Poplawski P., Boguslawska J., Tanski Z., Nauman A. Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors. PLoS One 2010, 27(10):e13690. Oct 27.
18. Ribeiro L.A., Bacci M.L., Seren E., Tamanini C., Forni M. Characterization and differential expression of vascular endothelial growth factor isoforms and receptors in swine corpus luteum throughout estrous cycle. Mol. Reprod. Dev. 2007, 74(2):163-171. Feb.
19. Shepard P.J., Hertel K.J. The SR protein family. Genome Biol. 2009, 10(10):242.
20. Smith P.J., Zhang C., Wang J., Chew S.L., Zhang M.Q., Krainer A.R. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum. Mol. Genet. 2006, 15(16):2490-2508.
21. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
22. Wang Z., Burge C.B. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 2007, 14(5):802-813. May, Epub 2008 Mar 27.
23. Wang J., Smith P.J., Krainer A.R., Zhang M.Q. Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Res. 2005, 33(16):5053-5062. Sep 7.
24. Woolard Jeanette, Bevan Heather S., Harper Steven J., Bates David O. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation 2009, 16(7):572-592. Oct.
25. Xing Y., Lee C. Alternative splicing and RNA selection pressure evolutionary consequences for eukaryotic genomes. Nat. Rev. Genet. 2006, 7:499-509.
26. Zachary I. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 2003, 31:1171-1177.
27. Zhang X.H., Kangsamaksin T., Chao M.S., Banerjee J.K., Chasin L.A. Exon inclusion is dependent on predictable exonic splicing enhancers. Mol. Cell. Biol. 2005, 25(16):7323-7332. Aug.